{"file_path": "/Users/sz904/Desktop/11711/LTI_Neural_Navigator/data/2024-02-26/chunk_paper_txt/Rita_Singh_A_Gene-Based_Algorithm_for_Identifying_Factors_That_May_Affect_a_Speaker\u2019s_Voice_chunk_6.txt", "num_qa_pairs": 10, "qa_list": [{"question": " What does Table 1 summarize?", "answer": " Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section.", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " What information is provided in Table 1 for each syndrome listed?", "answer": " For each syndrome listed in Table 1, the information includes the corresponding implicated genes that are also discovered to be chainlink genes, the overall counts of level-1 and level-2 chainlink genes, and the number of additional pathways they collectively connect to.", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " What phenotypic effects on speech are reported for SPEN?", "answer": " Delayed speech", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " Which gene is associated with impaired speech in the information given in the text?", "answer": " RBM8A", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " What are the reported effects on speech for DISP1, LEFTY1, LEFTY2, and BPNT1?", "answer": " Apraxia", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " How many genes are implicated in the microarray studies that also form voice chains for DISP1, LEFTY1, LEFTY2, and BPNT1?", "answer": " 60", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " What phenotypic effects on speech are reported for SLC3A1?", "answer": " Apraxia or Idiosyncratic", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " What are the phenotypic effects on speech reported for FOXP1?", "answer": " Delayed, Idiosyncratic, Impaired, and Dysarthric", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " What phenotypic effects on speech are reported for FGFR3?", "answer": " Delayed or Absent speech", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}, {"question": " Which gene is associated with no significant anomaly reports in terms of speech effects?", "answer": " CCNE2", "ref_chunk": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}], "doc_text": "the rows and columns of this table are explained in detail in Appendix A. Table 1 summarizes some of the information in Table A1 to help understand the analysis given in the next section. The information given in Table 1 includes, for each syndrome listed in it, the corresponding implicated genes that are also discovered to be chainlink genes by the algorithm proposed in this paper; the overall counts of level-1 and level-2 chainlink genes for each syndrome, along with the number of additional pathways they collectively connect to (in parentheses); and the corresponding phenotypic effects on speech that have been reported in the scienti\ufb01c literature. 9 of 33 Entropy 2023, 25, 897 Syndrome 1p36 1q21.1\u2013q21.2 1q41\u2013q42 1q43\u2013q44 2p16.1\u2013p15 2p21 2q23.1 2q32\u2013q33 2q37.3 3p13 3q13.31 3q29 4p16.3 4q21 5p (5p15.2 and/or (5p15.3 or 5p15.33)) 5q14.3 5q33.1 5q35.3 6pter\u2013p24 6q25.3 7p21 7q11.23 8p23.1 8q22.1 10 of 33 Table 1. Information about level-1 and level-2 voice chain ensembles for 76 chromosomal microdele- tion syndromes. For each syndrome, the corresponding implicated gene (culled from medical literature, with details given in the Appendix A) that was also discovered to be a chainlink gene by the proposed algorithm in either level-1 or level-2 chains is listed in the second column. The number of chainlink genes (i.e., genes that have chains that connect to the ACC biological pathway of FOXP2) is shown in the third and fourth columns for level-1 and level-2 chains, respectively. The total number of pathways that they collectively in\ufb02uence is indicated next to each count, in parentheses. The observed phenotypic effects on speech are given in the last column. Del: delayed speech; Imp: impaired speech; Norm: normal speech; Abs: absent speech; Apr: apraxia; Dys: dysarthria; Idio: idiosyncratic. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech SPEN 1 (10) 226 (3152) Del [9], or Abs RBM8A, GJAS \u2013 41 (906) Del [10] or Imp [11] DISP1, LEFTY1, LEFTY2, BPNT1 \u2013 60 (1020) Apr [12] AKT3 \u2013 78 (903) Del, Imp, or Abs \u2013 17 (508) Dys, Apr, or Imp [13] SLC3A1 \u2013 24 (557) Apr or Idio [14] \u2013 2 (31) Del or Imp COL3A1, COL5A2, GTF3C3, CASP8, CASP10 \u2013 62 (1429) Abs HDAC4 \u2013 38 (330) Imp [15] FOXP1 \u2013 8 (48) Del, Idio, Imp and Dys (all severe), Apr [16] DRD3, GAP43, LSAMP \u2013 5 (56) Imp [17] or Abs PAK2, DLG1 \u2013 24 (413) Del FGFR3 1 (25) 44 (495) Del [18] or Abs \u2013 41 (696) Del or Abs; Imp [19,20] TERT, CTNND2 \u2013 37 (500) Del, Abs, and Apr [21] MEF2C \u2013 7 (275) Abs RPS14 \u2013 17 (153) Dys [22] NSD1 1 (8) 47 (653) Norm [23] or Del FOXC1, GMDS \u2013 41 (416) Del ARID1B \u2013 21 (363) Del, Apr, Dys [24] TWIST1 \u2013 18 (243) Del [25] ELN, LIMK1, GTF2IRD1, GTF2I \u2013 35 (536) Norm or Del GATA4 \u2013 49 (337) No signi\ufb01cant anomaly reports CCNE2 \u2013 13 (152) Del Entropy 2023, 25, 897 Syndrome 8q24.11\u2013q24.13 9p24.3 9q34.3 10pter\u2013p13 or 10p14\u2013p15.1 10q23 10q26 11p11.2\u2013p12 11p13\u2013p12 11p15.5 11q13.3 11q23 11q23.3-q25 12q14.3 13q12.3 13q14 13q22.3 13q33\u2013q34 14q11\u2013q22 14q22.1\u2013q23.1 14q32.2 15q11.2 15q11\u2013q13 15q11\u2013q13 15q13.3 15q24 16p11.2 16p12.2\u2013p11.2 16p12.1 16p13.11 16p13.3 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains EXT1 EHMT1 GATA3 PTEN, BMPR1A DOCK1 EXT2 PAX6, SLC1A2, PRRG4 IGF2 FGF4, FGF3, FADD FLI1, JAM3 HMGA2 RB1 EDNRB SOX1, ARHGEF7 PAX9, SUPT16H, CHD8, RALGAPA1 PTGDR, BMP4 DLK1, MEG3 NIPA1, NIPA2, CYFIP1, TUBGCP5 NDN, SNRPN UBE3A CHRNA7, OTUD7A SIN3A SH2B1, TBX6, CORO1A SH2B1 MYH11 CREBBP, TRAP1 No. of Genes in {VN1} No. of Genes in {VN2} \u2013 21 (211) 1 (9) 3 (13) 1 (62) 46 (718) \u2013 49 (796) 1 (107) 59 (1003) \u2013 48 (708) \u2013 46 (737) \u2013 23 (342) 1 (347) 50 (1243) \u2013 11 (608) \u2013 77 (1421) \u2013 119 (1522) \u2013 9 (108) \u2013 6 (119) \u2013 46 (595) \u2013 3 (37) \u2013 30 (635) \u2013 173 (2021) \u2013 41 (530) \u2013 23 (242) \u2013 11 (72) \u2013 30 (230) \u2013Same as above\u2013 \u2013 8 (47) \u2013 38 (623) 1 (1) 70 (1067) 1 (1) 106 (1682) \u2013 17 (157) \u2013 6 (116) 1 (140) 122 (1532) 11 of 33 Reported Effects on Speech Del Del, Dys, Apr [26] Del [27], Apr [28] and Abs Sensorineural hearing loss Del or Abs; Imp [29] Imp; Del [30] Idio, Dys, Del, Apr [31] Imp [32] Imp [33] Del [34] Imp [35] Dysarthric, Abs [36]; Imp [37] Imp, Del, Apr [38] Abs, Imp [38] or Del [39] Del [40] Norm [41] Norm [41] Apr Del [42] or Abs Imp [43] Del; Idio [44] Del Del or Imp Abs; Imp [45] Imp or Idio Del or Imp Apr [46]; Dys [47], Del or Imp Del or Imp Del Del [48] Apr, Dys, Imp or Del [49] Entropy 2023, 25, 897 Syndrome 16q22 16q24.3\u2013q24.2 17p11.2 17p13.1 17p13.3 17q11.2 17q12 17q21.31 17q23.1\u2013q23.2 17q24.3\u2013q24.2 18q 19p13.13 19q13.11 20p12.3 22q11.2 22q12.2 22q13.3 Xp11.3 Xp21 Xq28 (a) Xq28 (b) Yq11 12 of 33 Table 1. Cont. Implicated Genes from Microarray Studies That Also form Voice Chains No. of Genes in {VN1} No. of Genes in {VN2} Reported Effects on Speech CBFB 1 (2) 79 (830) \u2013Not available\u2013 CDH15, ZNF778, ZFPM1 \u2013 28 (307) Del or Imp [50] LLGL1, UBB \u2013 36 (845) Del; Dys [51] KCNAB3, GUCY2D, TP53, TRAPPC1, MPDU1, FXR2, EFNB3 2 (214) 74 (1387) Abs PAFAH1B1, YWHAE \u2013 37 (487) Del [52] NF1 \u2013 40 (620) No signi\ufb01cant issues HNF1B, LHX1, CCL3L3 1 (124) 59 (890) Del or Imp KANSL1, MAPT, CRHR1 2 (68) 46 (740) Del or Abs \u2013 28 (307) Del [53] ABCA5, MAP2K6, SOX9 \u2013 22 (720) Del [54] MBP \u2013 122 (1666) Del [55] or Imp [56] 2 (263) 131 (2080) Del; Imp [57] UBA2, WTIP 1 (23) 22 (283) Del or Abs; Imp [58] BMP2 \u2013 13 (415) Del or Imp [59] TBX1, COMT, TOP3B \u2013 66 (1294) Apr, Dys, Del or Imp [60] NF2"}